Finance

Lists
Why is AKTX down 8,35%?
Dive Deeper
AKTX:NASDAQ
Akari Therapeutics PLC
7,24 $
-8,35%
(-0,66) 1D
7,96 $
+9,94% (+0,72)
After hours
Closed: 14 қаз., 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AKTX...
Open
8,10 $
High
8,10 $
Low
7,19 $
Mkt. cap
16,54 млн
Avg. vol.
69,48 мың
Volume
4,00
52-wk high
39,64 $
52-wk low
3,02 $
EPS
-330,40 $
Beta
1,43
Shares outstanding
1,14 млн
No. of employees
5
Open
8,10 $
High
8,10 $
Low
7,19 $
Mkt. cap
16,54 млн
Avg. vol.
69,48 мың
Volume
4,00
52-wk high
39,64 $
52-wk low
3,02 $
EPS
-330,40 $
Beta
1,43
Shares outstanding
1,14 млн
No. of employees
5
News stories
From web sources and news partners
About Akari Therapeutics PLC
CEO-
Employees5
Founded2004
HeadquartersТампа, Флорида, Америка Құрама Штаттары
Sector-
Websiteakaritx.com
Analyst ratings
Based on 3 analysts giving stock ratings to AKTX in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for AKTX in the last 3 months.
Highest
Current 7,24 $
30,00 $ (+314,36%)
Average
25,50 $ (+252,21%)
Lowest
19,50 $ (+169,34%)
Analyst
Recommendation
Action
Price target
Projected
Date
Sean Lee CFA
H.C. Wainwright
Buy
Reiterated
27,00 $
+272,9%
10/01/2026
Matthew Venezia
Alliance Global Partners
Buy
Reiterated
19,50 $
+169,3%
09/16/2026
Jason McCarthy
Maxim Group
Buy
Maintained
30,00 $
+314,4%
08/18/2026
Aydin Huseynov
Ladenburg Thalmann & Co.
Buy
Initiated
40,00 $
+452,5%
01/05/2026
James Molloy
Alliance Global Partners
Buy
Reiterated
7,00 $
-3,3%
11/19/2025
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
249,00 м.
1,09 млн
1,46 млн
2,08 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,98 млн
2,14 млн
2,17 млн
2,52 млн
Operating expense
2,22 млн
3,23 млн
3,63 млн
4,60 млн
Total operating expenses
2,22 млн
3,23 млн
3,63 млн
4,60 млн
Operating income
-2,22 млн
-3,23 млн
-3,63 млн
-4,60 млн
Other non operating income
253,00 м.
3,20 млн
274,00 м.
-99,00 мың
EBT including unusual items
-7,49 млн
-5,21 млн
-15,31 млн
-4,81 млн
EBT excluding unusual items
-2,12 млн
-998,00 м.
-3,35 млн
-4,81 млн
Income tax expense
-1,09 млн
85,00 мың
-859,00 м.
-
Effective tax rate
14,53%
-1,63%
5,61%
-
Other operating expenses
-
-
-
-
Net income
-6,40 млн
-5,30 млн
-14,46 млн
-4,81 млн
Net profit margin
-
-
-
-
Earnings per share
-1,06
-
-
-
Interest and investment income
1,00 мың
-
-
-
Interest expense
-121,00 м.
-723,00 м.
-61,00 мың
-80,00 мың
Net interest expenses
-120,00 м.
-723,00 м.
-61,00 мың
-80,00 мың
Depreciation and amortization charges
-
-
-
-
EBITDA
-2,22 млн
-3,22 млн
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google қолданбалары